Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    21067381 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura
Interventions: Drug: Medical Standard of Care for ITP;   Biological: Romiplostim
2 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia;   Glioblastoma
Intervention: Drug: Romiplostim

Study has passed its completion date and status has not been verified in more than two years.